Citigroup
IMUC

Citigroup’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History

Citigroup’s Portfolio IMUC Stock Details IMUC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-543
Closed -$3K – 7559
2016
Q3 		$3K Hold
543
– – ﹤0.01% 6908
2016
Q2 		$5K Sell
543
-15
-3% -$154 ﹤0.01% 6807
2016
Q1 		$6K Sell
558
-235
-30% -$2.64K ﹤0.01% 6978
2015
Q4 		$11K Buy
793
+250
+46% +$4.13K ﹤0.01% 6799
2015
Q3 		$9K Hold
543
– – ﹤0.01% 6524
2015
Q2 		$10K Hold
543
– – ﹤0.01% 6498
2015
Q1 		$11K Buy
543
+293
+117% +$7.36K ﹤0.01% 6445
2014
Q4 		$7K Buy
250
+110
+79% +$3.17K ﹤0.01% 6621
2014
Q3 		$5K Sell
140
-641
-82% -$24.7K ﹤0.01% 6617
2014
Q2 		$35K Buy
781
+656
+525% +$31.7K ﹤0.01% 5436
2014
Q1 		$6K Sell
125
-688
-85% -$33.6K ﹤0.01% 6577
2013
Q4 		$30K Buy
813
+574
+240% +$54.4K ﹤0.01% 5999
2013
Q3 		$24K Sell
239
-136
-36% -$14.9K ﹤0.01% 5820
2013
Q2 		$29K Buy
+375
New +$35.9K ﹤0.01% 5666

Other funds holding IMUC

SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $490M AUM 35.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return